Qt Imaging Holdings (QTI) Net Income towards Common Stockholders (2021 - 2026)
Qt Imaging Holdings (QTI) posted quarterly Net Income towards Common Stockholders of -$3.4 million for Q1 2026, up 69.41% year-over-year from -$2.0 million in Q1 2025, and down 145.38% quarter-over-quarter from -$1.4 million in Q4 2025.
Qt Imaging Holdings (QTI) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends
Qt Imaging Holdings (QTI) has reported Net Income towards Common Stockholders for 6 consecutive years, with -$3.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders rose 69.41% year-over-year to -$3.4 million; the TTM figure through Mar 2026 stood at -$13.4 million (up 45.89% YoY), while the FY2025 annual figure was -$21.1 million, down 48.78% from the prior year.
- Net Income towards Common Stockholders declined to -$3.4 million in Q1 2026 per QTI's latest filing, from -$1.4 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at -$382333.0 in Q1 2022 and bottomed at -$11.1 million in Q1 2025.
- Historically, Net Income towards Common Stockholders has averaged -$3.1 million across 5 years, with a median of -$1.8 million in 2023.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders tumbled 969.49% — and 2026, when it surged 69.41%.
- Qt Imaging Holdings' Net Income towards Common Stockholders stood at -$1.6 million in 2022, then advanced by 6.44% to -$1.5 million in 2023, then plunged by 131.02% to -$3.5 million in 2024, then jumped by 60.21% to -$1.4 million in 2025, then plunged by 145.38% to -$3.4 million in 2026.
- Business Quant data shows QTI's Net Income towards Common Stockholders at -$3.4 million in Q1 2026, -$1.4 million in Q4 2025, and -$4.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Qt Imaging Holdings | 42.71 Mn | 31.79 Mn | 3.06 Mn | -11.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.07 Mn |
| Mar 31, 2026 | -3.41 Mn |
| Dec 31, 2025 | -1.39 Mn |
| Sep 30, 2025 | -4.56 Mn |
| Jun 30, 2025 | -4.00 Mn |
| Mar 31, 2025 | -11.14 Mn |
| Dec 31, 2024 | -3.49 Mn |
| Sep 30, 2024 | -3.62 Mn |
| Jun 30, 2024 | -6.43 Mn |
| Mar 31, 2024 | -4.30 Mn |
| Dec 31, 2023 | -1.51 Mn |
| Sep 30, 2023 | -1.38 Mn |
| Jun 30, 2023 | -1.33 Mn |
| Mar 31, 2023 | -1.81 Mn |
| Dec 31, 2022 | -1.61 Mn |
| Sep 30, 2022 | -1.08 Mn |
| Jun 30, 2022 | -846,652.00 |
| Mar 31, 2022 | -382,333.00 |
| Dec 31, 2021 | -871,859.00 |
| Sep 30, 2021 | -204,317.00 |